Image Credit: Korawat photo shoot / Shutterstock.com Semaglutide is an incretin mimetic medication that increases the release of insulin from the pancreas and, as a result, is used to treat type 2 ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose management, weight loss and lower insulin requirements. Semaglutide (known by its ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

"People think it's a quick fix but, trust me, it's not." Dr Stephen Childs found insulin, but no semaglutide, in a product analysed for the BBC BBC Investigations spoke to several people who ...

Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits, but is officially ...

Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...

Compounded semaglutide enhances insulin secretion, suppresses glucagon release, and ultimately lowers blood sugar levels, making it an effective tool for diabetes management. Its ability to increase ...

with the emergence of metformin and more recently semaglutide and dulaglutide. However, despite these alternative diabetes treatments, insulin is still essential for people living with type 1 ...

Further information Dear stakeholders, As you will be aware, the Department for Health & Social Care has asked NICE to carry out a Single Technology Appraisal of TSID 11940 Basal insulin ...